Transplantation, AutologousHematopoietic Stem Cell TransplantationTransplantation, HomologousStem Cell TransplantationTransplantation ConditioningGraft vs Host DiseaseBone Marrow TransplantationPeripheral Blood Stem Cell TransplantationMultiple MyelomaMyeloablative AgonistsHematologic NeoplasmsStem CellsMelphalanTreatment OutcomeWhole-Body IrradiationCombined Modality TherapyLiver TransplantationHematopoietic Stem CellsRemission InductionGraft SurvivalRecurrenceHematopoietic Stem Cell MobilizationAntineoplastic Combined Chemotherapy ProtocolsSalvage TherapyDisease-Free SurvivalLymphoma, Non-HodgkinTissue DonorsRetrospective StudiesTransplantation ChimeraSurvival AnalysisKidney TransplantationUnrelated DonorsSurvival RateCyclophosphamideBusulfanHodgkin DiseaseHistocompatibility TestingCell TransplantationCarmustineBone Marrow PurgingAntigens, CD34EtoposideCord Blood Stem Cell TransplantationHistocompatibilityImmunosuppressive AgentsGraft vs Tumor EffectCytarabineTime FactorsLeukemia, Myeloid, AcuteFollow-Up StudiesHeart TransplantationVincristineLeukemiaGranulocyte Colony-Stimulating FactorGraft RejectionMyelodysplastic SyndromesThiotepaVidarabineLung TransplantationLeukapheresisMesenchymal Stem Cell TransplantationHematopoiesisPrognosisTransplantation ImmunologyBone Marrow CellsTransplantationHLA AntigensSiblingsLymphomaCell DifferentiationChimerismThalidomideDexamethasoneEmbryonic Stem CellsGraft vs Leukemia EffectDonor SelectionOrgan TransplantationNeoplasm, ResidualAmyloidosisAntibodies, Monoclonal, Murine-DerivedBlood Transfusion, AutologousBone MarrowDoxorubicinAntineoplastic Agents, AlkylatingAntineoplastic AgentsCells, CulturedAdult Stem CellsLymphoma, Mantle-CellIslets of Langerhans TransplantationAcute DiseaseLiving DonorsPrednisonePrecursor Cell Lymphoblastic Leukemia-LymphomaT-LymphocytesHematologic DiseasesImmunosuppressionBoronic AcidsFlow CytometryPancreas TransplantationCyclosporine